text:
Dragan M. Djuric (born in 1961 in Krusevac town, central part of Serbia), received his MD in 1987, MS in 1991 and PhD degree in 1993 from the Faculty of Medicine University of Belgrade. Academic positions: research assistant (1989-1991), assistant (1991-1994), assistant professor (1994-1999), associate professor (1999-2008), full professor of medical physiology at the Faculty of Medicine University of Belgrade. Postdoctoral training obtained in Germany (Max Planck Institute for Physiological and Clinical Research - Kerckhoff Heart Centre, Bad Nauheim, 1998, 2001-2002), and USA (College of Medicine, University of South Alabama, Mobile, 2000). From 1997-2000 he was head at the Centre for Atherosclerosis and Vascular Biology in the Dedinje Cardiovascular Institute, Belgrade. In period 2006-2009 he was a director, than in period 2009-2012 he was a chair of the Institute of Medical Physiology “Richard Burian” at the Faculty of Medicine University of Belgrade. He initiated and co-founded PhD program in physiological sciences (2009), and from that time he is a chairman of that program at the Belgrade University Faculty of Medicine. He initiated and co-founded the establishment of the Yugoslav Atherosclerosis Society in 1998, then he was a first secretary general (1998-2002). He was a president of the executive committee and assembly of the Serbian Physiological Society (2006-2013), president of the program and nominating committee of the Serbian Physiological Society (2013-2017), and president of the assembly of the Serbian Physiological Society (2018-2021). Dr. Djuric also had a lot of international responsibilities: 2000-present, Council Member, International Atherosclerosis Society; 2003-2013 Council Member, Federation of European Physiological Societies (FEPS); 2005-2009 Council Member, International Union of Physiological Sciences (IUPS); 2006-2014 Council Member, International Society for Pathophysiology; 2011-present, Member, Steering Committee, Global Network for Global Fight against Cardiovascular Diseases, International Academy of Cardiovascular Sciences IACS). He organized/co-organized the first Yugoslav congress on atherosclerosis (Belgrade, 2001), satellite symposium of XIV International Symposium on Atherosclerosis (IAS Belgrade, 2006), international conference on nutrition and cardiovascular health (Novi Sad, 2007), and 2nd European section meeting of the International Academy of Cardiovascular Sciences (Belgrade, 2015). He also organized/co-organized 3 congresses of physiological sciences (2005, 2009 and 2014, respectively) as well as 7 conferences and meetings of physiological sciences with international participation in Serbia including joint Serbian-Slovak and Serbian-Hungarian bilateral physiological meetings (2003, 2004, 2008, 2011, 2013, 2016, 2017, respectively). He was also organizer of the jubilee symposium on the occasion of the 90th anniversary of the founding of the Institute of Medical Physiology “Richard Burian“at Belgrade University Faculty of Medicine (2011). He organized the celebration of the 80th anniversary of the installation of a memorial plaque in the lobby of Institute of Medical Physiology, Faculty of Medicine University of Belgrade, in honour and memory to Scottish doctor Elsie Maud Inglis, which was a heroin in the First World War and leader of the famous military unit entitled “Scottish Women's Hospitals”) (2009). He serves as a member of the International Lipid Expert Panel (ILEP) and Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group. He also served as a member of Homocysteine Expert Panel in Germany, and was a member of the scientific/organizing committee at the global international conference entitled “Advances and Controversies in B-Vitamins and Choline” (Leipzig 2012). Two times he served as a co-chair of the sessions at congresses of of the Federation of European Physiological Societies (FEPS) (Bratislava 2007, Budapest 2014); at FEPS congresses (Bratislava 2007, Budapest 2014) he organized thematic symposia on endothelial pathophysiology, risk factors and vasculoprotective strategy and nutrition. and also co-organized the symposium on nutrition and cardiovascular health (Budapest 2014). He held a few international grants and contracts (Kerckhoff Klinik GmbH-Bad Nauheim/Germany, Solvay Pharma-Hannover/Germany, and Pfizer GmbH-Belgrade/Serbia). He is principal investigator in national-funded grants (since 2005), and now he participates as a member of the managing committee in COST action [CA16225 RS] “Realising the therapeutic potential of novel cardioprotective therapies (EUCARDIOPROTECTION)”. He also participated as a member of the managing committee in COST action [BM1005 Biomedicine and Molecular Biosciences] “Gasotransmitters: from basic science to therapeutic applications (MC, ENOG: European Network on Gasotransmitters, 2011), COST action CM1203 Chemistry and Molecular Sciences and Technologies (CMST) “Polyoxometalate chemistry for molecular nanoscience (PoCheMoN, 2012), and in ScreenPro FH (Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe, 2015). He is also serving as a member of the International Lipid Expert Panel (ILEP) from 2015. He published more than 700 different kinds of publications in English, German, Russian and Serbian language, with 112 full-length papers in peer-reviewed journals indexed in JCR (CC/SCI/SCIe) plus 15 papers indexed only in PubMed, and 30 chapters in books/monographs. Dr. Djuric also wrote or edited 4 monographs about endothelium, atherosclerosis and nutrition, and edited/co-edited 12 books of abstracts from scientific meetings. His research interests include studies on the roles/effects of different compounds in cardiovascular system, ie. histamine, homocysteine and its thiolactone metabolites, other sulphur-containing acids (methionine, cysteine, N-acetyl-L-cysteine), folic acid, vitamin B6, L-arginine, vitamin C, then gasotransmitters (NO, H2S, CO), oxidative stress, cardiovascular prevention, exercise, novel cardiovascular and cancer biomarkers, NMDA receptors in cardiac and neural hyperexcitability, cardiac failure diabetes mellitus, nutrition and nutraceuticals. He was cited more than 1000 times (ResearchGate), and was invited for presenting the lectures 70 times in Serbia as well as 38 times abroad at different foreign institutions and international meetings (citations 529 times according to Web of Science with self citation excluded, H-index 14, on January 2018). He was a co-editor of the translation to Serbian language of the whole edition of the Textbook of Medical Physiology by Guyton AC and Hall JE in 2008 (Saunders 11th ed.), co-editor of the chapter translation of the Ganong's Review of Medical Physiology by Barrett KE, Barman SM, Boitano S, Brooks HL in 2015 (McGraw-Hill/Lange Basic Science 24 ed.) as well as editor/co-editor of 4 textbooks and demonstration manual in the field of medical physiology in Serbian language. He was serving on editorial boards of Canadian Journal of Physiology and Pharmacology, Molecular and Cellular Biochemistry, Acta Physiologica Hungarica, Experimental and Clinical Cardiology, Pathophysiology, Mediterranean Journal of Nutrition and Metabolism, Medical Science Monitor Basic Research, Curent Research: Cardiology, Serbian Journal for Experimental and Clinical Research, Archives of Medical Sciences - Atherosclerosis Diseases, and a member of editorial board of CV Network (global bulletin of the International Academy of Cardiovascular Sciences) in period 2007-2015. He was reviewer many times in international and domestic scientific journals, and guest editor in a few special issues, ie. 2006 - Acta Physiologica Hungarica; 2008 and 2016 - Canadian Journal of Physiology and Pharmacology; 2009 - General Physiology and Biophysics; 2012 - Medicinal Chemistry, and in 2017 – Current Medicinal Chemistry. He was abstract grader at large international meetings, reviewer on different grant’s proposals (Serbia, Poland, Hungary), foreign member of dissertation committee (Slovakia), proposer for the position of full professorship in the field of physiology and pathophysiology (Romania), and proposer for prestigious fellowships in Germany, Canada and USA. Professor Dr. Dragan M. Djuric was elected as a fellow of the International Academy of Cardiovascular Sciences (2011). He was awarded with Serbian Physiological Society Award for Lifetime Achievement in Physiological Sciences (2016), Lifetime Achievement Award in Cardiovascular Science, Medicine and Surgery by the International Academy of Cardiovascular Sciences (2015), Samuel Racz Medal and Honorary member for the contribution in physiology from the Hungarian Physiological Society (2010), Honorary member of the Bulgarian Society for Cell Biology (2009), Honorary member of the Romanian Society for Laboratory Medicine (2008), Medal of the Yugoslav Society of Cardiology (2002), and Belgrade City October Award (1987).
FULL LENGTH PAPERS PUBLISHED IN JOURNALS INDEXED IN CURRENT CONTENTS, SCIENCE CITATION INDEX OR SCIENCE CITATION INDEX EXPANDED 1.	Jeremic J, Nikolic Turnic T, Zivkovic V, Jeremic N, Milosavljevic I, Srejovic I, Obrenovic R, Jancic S, Rakocevic M, Matic S, Djuric D, Jakovljevic V. Vitamin b complex mitigates cardiac dysfunction in high-methionine diet-induced hyperhomocysteinemia. Clin Exp Pharmacol Physiol. 2018 Mar 6. doi: 10.1111/1440-1681.12930. [Epub ahead of print] 2.	Stojanović M, Todorović D, Šćepanović L, Mitrović D, Borozan S, Dragutinović V, Labudović-Borović M, Krstić D, Čolović M, Djuric D. Subchronic methionine load induces oxidative stress and provokes biochemical and histological changes in the rat liver tissue. Mol Cell Biochem. 2018 Feb 8. doi: 10.1007/s11010-018-3311-2. [Epub ahead of print] 3.	Plecevic S, Jakovljevic B, Savic M, Zivkovic V, Nikolic T, Jeremic J, Milosavljevic I, Srejovic I, Tasic N, Djuric D, Jakovljevic V. Comparison of short-term and medium-term swimming training on cardiodynamics and coronary flow in high salt-induced hypertensive and normotensive rats. Mol Cell Biochem. 2018 Jan 27. doi: 10.1007/s11010-018-3291-2. [Epub ahead of print] 4.	Stevanovic J, Zivkovic V, Bolevich S, Zaric G, Cekerevac I, Djuric D, Jakovljevic V, Nikolic T, Djuric D. (2017) Effects of selective phosphodiesterase-2 and phosphodiesterase-3 inhibition on coronary flow and oxidative stress in the isolated rat heart. Acta Poloniae Pharmaceutica - Drug Research, vol. 74, no. 6, pp. 1691n1698, ISSN 0001-6837. 5.	Uzelac JJ, Stanić M, Krstić D, Čolović M, Djurić D. Effects of homocysteine and its related compounds on oxygen consumption of the rat heart tissue homogenate: the role of different gasotransmitters. Mol Cell Biochem. 2017 Nov 29. doi: 10.1007/s11010-017-3238-z. [Epub ahead of print] 6.	Kornjača D, Živković V, Krstić D, Čolović M, Đurić M, Stanković S, Mutavdžin S, Jakovljević V, Đurić D. (2018) The effects of acute hyperhomocysteinemia induced by DL-homocysteine or DL-homocysteine thiolactone on serum biochemical parameters, plasma antioxidant enzyme and cardiac acetylcholinesterase activities in the rat. Archives of Biological Sciences, 2018 OnLine-First (00):41-41, doi.org/10.2298/ABS170731041K 7.	Milovanovic P, Hrncic D, Radotic K, Stankovic M, Mutavdzic D, Djonic D, Rasic-Markovic A, Djuric D, Stanojlovic O, Djuric M. (2017) Moderate hyperhomocysteinemia induced by short-term dietary methionine overload alters bone microarchitecture and collagen features during growth. Life Sci. 2017 Dec 15; 191:9-16. doi: 10.1016/j.lfs.2017.10.008. 8.	Stojanovic M, Scepanovic Lj, Todorovic D, Mitrovic D, Scepanovic V, Scepanovic R, Ilic S, Scepanovic T, Labudovic Borovic M, Milicevic Z, Dragutinovic V, Borozan S, Lalic I, Sanja Despotovic S, Djuric D (2018). Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-L-cysteine. Mol Cell Biochem. 440(1-2):53-64. doi: 10.1007/s11010-017-3155-1. 9.	Cicero AFG, Colletti A, Bajraktari G , Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Z, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M *on behalf of the International Lipid Expert Panel (ILEP). (2017) Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel (2017) Nutrition Reviews, 75 (9): 731–767, nux047, https://doi.org/10.1093/nutrit/nux047. (The article has been co-published with permission in Archives of Medical Science and Nutrition Reviews). 10.	Cicero AFG, Colletti A, Bajraktari G , Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Z, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M *on behalf of the International Lipid Expert Panel (ILEP). Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel (2017) Archives of Medical Science 13(5):966–1005, doi: 10.5114/aoms.2017.69326. (The article has been co-published with permission in Archives of Medical Science and Nutrition Reviews). 11.	Stojic IM, Zivkovic VI, Srejovic IM, Nikolic TR, Jeremic NS, Jeremic JN, Djuric DM, Jovicic N, Radonjic KG, Bugarcic ZD, Jakovljevic VLJ, Novokmet SS. Cisplatin and cisplatin analogues perfusion through isolated rat heart: the effects of acute application on oxidative stress biomarkers. Mol Cell Biochem. 2018 Feb;439(1-2):19-33. doi: 10.1007/s11010-017-3132-8. 12.	Srejovic IM, Zivkovic VI, Nikolic TR, Jeremic N Jeremic, Stojic I, Jeremic J, Djuric D, Jakovljevic V. Modulation of N-methyl-D-aspartate receptors in isolated rat heart. Can J Physiol Pharmacol. 2017 Nov;95(11):1327-1334. doi: 10.1139/cjpp-2017-0056. 13.	Rosic G, Joksimovic J, Selakovic D, Jakovljevic V, Zivkovic V, Srejovic I, Djuric M, Djuric D. The beneficial effects of sulfur-containing amino acids on cisplatin-induced cardiotoxicity and neurotoxicity in rodents. Curr Med Chem. 2018 Jan 30;25(3):391-403. doi: 10.2174/0929867324666170705114456. 14.	Hrncic D, Rasic-Markovic A, Macut D, Mladenovic D, Susic V, Djuric D, Stanojlovic O. Sulfur - Containing Amino Acids in Seizures: Current State of the Art. Curr Med Chem. 2018 Jan 30;25(3):378-390. doi: 10.2174/0929867324666170609090613. 15.	Čolović MB, Vasić VM, Djuric DM, Krstić DZ. Sulphur-containing amino acids: protective role against free radicals and heavy metals. Curr Med Chem. 2018 Jan 30;25(3):324-335. doi: 10.2174/0929867324666170609075434. 16.	Nikolic T, Zivkovic V, Srejovic I, Stojic I, Jeremic N, Jeremic J, Radonjic K, Stankovic S, Obrenovic R, Djuric D, Jakovljevic V (2017) The effects of atorvastatin and simvastatin on oxidative stress in diet-induced hyperhomocisteinemia in wistar albino rats: a comparative study. Mol Cell Biochem. 2018 Jan;437(1-2):109-118. doi: 10.1007/s11010-017-3099-5. 17.	Stojanović M, Šćepanović Lj, Mitrović D, Šćepanović V, Šćepanović R, Djuric M, Ilić S, Šćepanović T, Djuric D. (2017) Different pathways involved in stimulatory effects of homocysteine on rat duodenal smooth muscle. Acta Veterinaria 67 (2), 254-270, doi: 10.1515/acve-2017-0021 18.	Stojic I, Srejovic I, Zivkovic V, Jeremic N, Djuric M, Stevanovic A, Milanovic T, Djuric D, Jakovljevic V. (2017) The effects of verapamil and its combinations with glutamate and glycine on cardiodynamics, coronary flow and oxidative stress in isolated rat heart. J Physiol Biochem. 73: 141-153. doi: 10.1007/s13105-016-0534-0 19.	Stojanovic M, Zivkovic V, Srejovic I, Jakovljevic V, Jeremic N, Djuric D. (2016) The role of hydrogen sulfide in homocysteine-induced cardiodynamic effects and oxidative stress markers in the isolated rat heart. Physiology International (Acta Physiologica Hungarica), vol. 103 (4), 428-438. doi: 10.1556/2060.103.2016.4.3 20.	Rasic-Markovic A, Hrncic D, Krstić D, Colovic M, Djuric E, Rankov-Petrović B, Susic V, Stanojlovic O, Djuric D. The effect of subchronic supplementation with folic acid and L-arginine on homocysteine induced seizures. Can J Physiol Pharmacol. 2016 Oct;94(10):1083-1089. 21.	Hrncic D, Mikić J, Rasic-Markovic A, Velimirović M, Stojković T, Obrenović R, Rankov-Petrović B, Susic V, Djuric D, Petronijević N, Stanojlovic O. Anxiety-related behavior in hyperhomocysteinemia induced by methionine nutritional overload in rats: role of the brain oxidative stress. Can J Physiol Pharmacol. 2016 Oct;94(10):1074-1082. 22.	Nikolic T, Zivkovic V, Srejovic I, Radovanovic D, Jeremic N, Jevdjevic M, Djuric D, Jakovljevic V. Acute effects of nandrolone decanoate on cardiodynamic parameters in isolated rat heart. Can J Physiol Pharmacol. 2016 Oct;94(10):1048-1057. 23.	Vasiljevic D, Veselinovic M, Jovanovic M, Jeremic N, Arsic A, Vucic V, Lucic-Tomic A, Zivanovic S, Djuric D, Jakovljevic V. (2016) Evaluation of the effects of different supplementation on oxidative status in patients with rheumatoid arthritis. Clin Rheumatol. 35(8):1909-15. 24.	Stojanović M, Šćepanović Lj, Bosnić O , Mitrović D, Jozanov Stankov O , Šćepanović V, Šćepanović R , Stojanović T , Ilić S , Djurić D. (2016) Effects of acute administration of D, L - homocysteine thiolactone on the antioxidative status of rat intestine and liver. Acta Veterinaria-Beograd 66 (1), 26-36. 25.	Nikolic T, Zivkovic V, Jevdjevic M, Djuric M, Srejovic I, Djuric D, Jeremic N, Djuric D, Bolevich S, Jakovljevic V. (2016) The effects of chronic administration of nandrolone decanoate on redox status in exercised rats. Mol Cell Biochem. 411(1-2):95-105. 26.	Arsic A, Vucic V, Glibetic M, Popovic T, Debeljak-Martacic J, Cubrilo D, Ahmetovic Z, Peric D, Borozan S, Djuric D, Barudzic N, Jakovljevic V. (2016) Redox balance in elite female athletes: differences based on sport types. J Sports Med Phys Fitness. 56(1-2):1-8. 27.	Milicic V, Zivkovic V, Jeremic N, Arsenijevic N, Djuric D, Jakovljevic VL. (2016) Coronary flow and oxidative stress during local anaphylactic reaction in isolated mice heart: the role of nitric oxide (NO). Mol Cell Biochem. 412: 221-227. 28.	Tasić N, Tasić D, Otašević P, Veselinović M, Jakovljević V, Djurić D, Radak Dj. (2015) Copper and zinc concentrations in atherosclerotic plaque and serum in relation to lipid metabolism in patients with carotid atherosclerosis. Vojnosanit Pregl. 72(9):801-6. 29.	Mladenović D, Petronijević N, Stojković T, Velimirović M, Jevtić G, Hrnčić D, Radosavljević T, Rašić-Marković A, Maksić N, Djuric D, Stanojlović O. (2015) Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats. PLoS One. 10(8):e0134434. 30.	Stojanovic Tosic JT, Jakovljevic VL, Zivkovic VV, Srejovic IM, Valdevit ZJ, Radovanovic DS, Djuric DM, Ahmetovic ZK, Peric DB, Cankovic MB, Jovanovic MS, Djordjevic DZ. (2015) Biphasic response of cardiodynamic adaptations to swimming exercise in rats. Gen Physiol Biophys. 30;34:301-10. 31.	Jeremic N, Petkovic A, Srejovic I, Zivkovic V, Djuric D, Jakovljevic V. (2015) Effects of ischemia and omeprazole preconditioning on functional recovery of isolated rat heart. Rev Bras Cir Cardiovasc 30(2):266-75. 32.	Misic MM, Jakovljevic VL, Bugarcic ZD, Zivkovic VI, Srejovic IM, Barudzic NS, Djuric DM, Novokmet SS. (2015) Platinum Complexes-Induced Cardiotoxicity of Isolated, Perfused Rat Heart: Comparison of Pt(II) and Pt(IV) Analogues Versus Cisplatin. Cardiovasc Toxicol 15(3):261-8. 33.	Pesic S, Milinkovic M, Vuletic M, Barudzic N, Zivkovic V, Jakovljevic V, Djuric D, Stojimirovic B. (2015) Assessment of Oxidative Status in Patients with Acute Kidney Injury: A Pilot Study. Chin J Physiol 30;58(2):124-33. 34.	Rasic-Markovic A, Rankov-Petrovic B, Hrncic D, Krstic D, Colovic M, Macut Dj, Djuric D, Stanojlovic O. (2015) The effect of subchronic supplementation with folic acid on homocysteine induced seizures. Acta Physiol Hung. 102(2):151-62. 35.	Tasic NM, Tasic D, Veselinovic M, Jakovljevic V, Djuric D, Radak D. (2015) Iron concentrations in atherosclerotic plaque and serum in patients with carotid atherosclerosis. Acta Physiol Hung. 102(2):143-50. 36.	Lopatina EV, Kipenko AV, Penniyaynen VA, Pasatetskaya NA, Djuric D, Krylov BV. (2015) Organotypic tissue culture investigation of homocysteine thiolactone cardiotoxic effect. Acta Physiol Hung. 102(2):137-42. 37.	Paspalj D, Nikic P, Savic M, Djuric D, Simanic I, Zivkovic V, Jeremic N, Srejovic I, Jakovljevic V. (2015) Redox status in acute ischemic stroke: correlation with clinical outcome. Mol Cell Biochem 406(1-2):75-81. 38.	Stojanović M, Šćepanović Lj, Hrnčić D, Rašić-Marković A, Djurić D, Stanojlović O. (2015) Multidisciplinary approach to nitric oxide signaling: focus on gastrointestinal and central nervous system. Vojnosanit Pregl 72 (7): 619-624. 39.	Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. (2015) Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin. Drug Saf. 14(6):935-55. (The article has been co-published with permission in Expert Opinion Drug Safety and Archives of Medical Science). 40.	Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. (2015) Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 16;11(1):1-23. (The article has been co-published with permission in Archives of Medical Science and Expert Opinion Drug Safety). 41.	Čolović MB, Vasić VM, Avramović NS, Gajić MM, Djurić DM, Krstić DZ (2015). In vitro evaluation of neurotoxicity potential and oxidative stress responses of diazinon and its degradation products in rat brain synaptosomes. Toxicol Lett 17; 233(1): 29-37. 42.	Jevđević M, Jovanović M, Jeremić N, Canković M, Jeremić J, Živković V, Srejović I, Đurić D, Jakovljević V (2015). Acute effects of nandrolone decanoate on oxidative stress in isolated rat heart. Archives of Biological Sciences, 67 (1): 331-337. 43.	Srejovic I, Jakovljevic V, Zivkovic V, Barudzic N, Radovanovic A, Stanojlovic O, Djuric DM (2015). The effects of the modulation of NMDA receptors by homocysteine thiolactone and dizocilpine on cardiodynamics and oxidative stress in isolated rat heart. Mol Cell Biochem 401(1-2):97-105. 44.	Radenković M, Djurić D, Janković R, Prostran M (2014). The analysis of transduction mechanisms associated with an acute action of homocysteine on isolated rat femoral artery. Acta Physiol Hung 101(4):448-60. 45.	Hrnčić D, Rašić-Marković A, Stojković T, Velimirović M, Puškaš N, Obrenović R, Macut D, Sušić V, Jakovljević V, Djuric D, Petronijević N, Stanojlović O (2014) Hyperhomocysteinemia induced by methionine dietary nutritional overload modulates acetylcholinesterase activity in the rat brain. Mol Cell Biochem 396(1-2):99-105. 46.	Raicevic S, Eventov-Friedman S, Bolevich S, Selakovic D, Joksimovic J, Djuric J, Globarevic-Vukcevic G, Djuric D, Jakovljevic V (2014). Correlation between oxidative stress and G6PD activity in neonatal jaundice. Mol Cell Biochem 395(1-2):273-9. 47.	Veselinovic M, Barudzic N, Vuletic M, Zivkovic V, Tomic-Lucic A, Djuric D, Jakovljevic V (2014). Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity. Mol Cell Biochem 391 (1-2):225-32. 48.	Hrncic D, Rasic-Markovic A, Macut D, Susic V, Djuric D, Stanojlovic O. (2014) Homocysteine thiolactone-induced seizures in adult rats are aggravated by inhibition of inducible nitric oxide synthase. Hum Exp Toxicol 33(5):496-503. 49.	Hrncic D, Rasic-Markovic A, Lekovic J, Krstic D, Colovic M, Macut D, Susic V, Djuric D, Stanojlovic O. (2014) Exercise decreases susceptibility to homocysteine seizures: the role of oxidative stress. Int J Sports Med 35(7):544-50. 50.	Aleksic D, Djokic D, Golubicic I, Jakovljevic V, Djuric D. (2013) The importance of the blood levels of homocysteine, folic acid and vitamin B12 in children with malignant diseases. J BUON. 18(4):1019-25. 51.	Zivkovic V, Jakovljevic V, Pechanova O, Srejovic I, Joksimovic J, Selakovic D, Barudzic N, Djuric D. (2013) Effects of DL-homocysteine thiolactone on cardiac contractility, coronary flow, and oxidative stress markers in the isolated rat heart: the role of different gasotransmitters. BioMed Research International, Hindawi Publishing Corporation, Volume 2013, Article ID 318471, 9 pages http://dx.doi.org/10.1155/2013/318471. 52.	Stojanović M, Šćepanović Lj, Mitrović D, Šćepanović V, Stojanović T, Stojković M, Ilić S, Đurić D. (2013) Rat duodenal motility in vitro: procinetic effects of D,L-homocysteine thiolactone and modulation of nitric oxide mediated inhibition. Arch Biol Sci 65(4): 1323-1330. 53.	Barudzic N, Turjacanin-Pantelic D, Zivkovic V I, Selakovic D, Srejovic I, Joksimovic J, Djuric DM, Jakovljevic VLj. (2013) The effects of cyclooxygenase and nitric oxide synthase inhibition on oxidative stress in isolated rat heart. Molecular and Cellular Biochemistry 381(1-2):301-311. 54.	Zivkovic V, Djuric D, Turjacanin-Pantelic D, Marinkovic Z, Stefanovic D, Srejovic I, Jakovljevic V. (2013) The effects of cyclooxygenase and nitric oxide synthase inhibition on cardiodynamic parameters and coronary flow in isolated rat hearts. Exp Clin Cardiol 18(2):e102-10. 55.	Hrncic D, Rasic-Markovic A, Bjekic-Macut J, Susic V, Djuric D, Stanojlovic O. (2013) Paradoxical sleep deprivation potentiates epilepsy induced by homocysteine thiolactone in adult rats. Exp Biol Med (Maywood) 238(1):77-83. 56.	Zivkovic V, Lazarevic P, Djuric D, Cubrilo D, Macura M, Vuletic M, Barudzic N, Nesic M, Jakovljevic V. (2013) Alteration in basal redox state of young male soccer players after a six-month training programme. Acta Physiol Hung 100(1):64-76. 57.	Djordjevic DZ, Cubrilo DG, Puzovic VS, Vuletic MS, Zivkovic VI, Barudzic NS, Radovanovic DS, Djuric DM, Jakovljevic VLj. (2012) Changes in athlete's redox state induced by habitual and unaccustomed exercise. Oxid Med Cell Longev 2012:805850. doi: 10.1155/2012/805850. 58.	Veselinovic M, Jakovljevic V, Jurisic-Skevin A, Toncev S, Djuric DM. (2012) Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study. Clin Rheumatol 31(12):1727-32. 59.	Zivkovic V, Jakovljevic V, Djordjevic D, Vuletic M, Barudzic N, Djuric D. (2012) The effects of homocysteine-related compounds on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart. Mol Cell Biochem 370(1-2):59-67. 60.	Veselinovic M, Jakovljevic V, Jurisic-Skevin A, Toncev S, Djuric DM. (2012) Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. Vasa 41(5):343-51. 61.	Hrnčić D, Rašić-Marković D, Bjekić-Macut J, Šušić V, Mladenović D, Djuric D, Stanojlovic O. (2012) Gaseous neurotransmitter nitric oxide: its role in experimental models of epilepsy. Arch Biol Sci (Belgrade) 64 (3): 1207-1216. 62.	Mladenović D, Radosavljević T, Hrnčić D, Rašić-Marković A, Puškaš N, Maksić N, Djuric D, Stanojlović O. Behavioral and electroencephalographic manifestations of thioacetamide-induced encephalopathy in rats. Can J Physiol Pharmacol. 2012; 90(9):1219-27. 63.	Djordjevic DZ, Cubrilo DG, Barudyic NS, Vuletic MS, Zivkovic VI, Nesic M, Radovanovic D, Djuric DM, Jakovljevic VLj. (2012) Comparison of blood pro/antioxidant levels before and after acute exercise in athletes and non-athletes. Gen Physiol Biophys 31: 211-219. 64.	Djoric P, Zeleskov-Djoric J, Stanisavljevic DM, Markovic ZD, Zivkovic V, Vuletic M, Djuric D, Jakovljevic V. (2012) Distal Venous Arterialization and Reperfusion Injury: Focus on Oxidative Status. Eur Surg Res 7; 48(4):200-207. 65.	Hrncic D, Rasic-Markovic A, Krstic D, Macut D, Susic V, Djuric D, Stanojlovic O. (2012) Inhibition of the neuronal nitric oxide synthase potentiates homocysteine thiolactone- induced seizures in adult rats. Med Chem 1;8(1):59-64. 66.	Peric T, Lj Jakovljevic V, Zivkovic V, Krkeljic J, Petrovic ZD, Simijonovic D, Novokmet S, Djuric DM, Jankovic SM. (2012) Toxic effects of palladium compounds on the isolated rat heart. Med Chem 1;8(1):9-13. 67.	Vujanac A, Jakovljevic V, Djordjevic D, Zivkovic V, Stojkovic M, Celikovic D, Andjelkovic N, Skevin AJ, Djuric D. (2012) Nitroglycerine effects on portal vein mechanics and oxidative stress in portal hypertension. World J Gastroenterol 28;18(4):331-9. 68.	Pesic S, Jakovljevic V, Djordjevic D, Cubrilo D, Zivkovic V, Jorga V, Mujovic V, Djuric D, Stojimirovic B. (2012) Exercise-induced changes in redox status of elite karate athletes. Chin J Physiol 29;55(1):8-15. 69.	Medjedovic S, Jakovljevic V, Djordjevic D, Randjelovic D, Koprivica Z, Petronijevic N, Tasic N, Pavlovic M, Vucinic Z, Sundric Z, Djuric DM. (2012) Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes. African Journal of Pharmacy and Pharmacology, vol. 6(5): 283-293. 70.	Marković AR, Hrnčić D, Macut D, Stanojlović O, Djuric D. (2011) Anticonvulsive effect of folic acid in homocysteine thiolactone-induced seizures. Cell Mol Neurobiol 31(8):1221-8. 71.	Jakovljevic VLj, Djordjevic DZ, Djuric DM. (2011) The effects of vitamin C and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart. Gen Physiol Biophys 30(3):293-300. 72.	Koprivica Z, Djordjevic D, Vuletic M, Zivkovic V, Barudzic N, Andjelkovic N, Djuric D, Iric-Cupic V, Krkeljic J, Jakovljevic V. (2011) Von Willebrand factor and oxidative stress parameters in acute coronary syndromes. Oxid Med Cell Longev 2011:918312. 73.	Cubrilo D, Djordjevic D, Zivkovic V, Djuric D, Blagojevic D, Spasic M, Jakovljevic V. (2011) Oxidative stress and nitrite dynamics under maximal load in elite athletes: relation to sport type. Mol Cell Biochem 355(1-2):273-9. 74.	Gostiljac D, Dorđević PB, Djurić D, Peruničić J, Lasica R, Colak E, Canovic F, Srećković VD, Ilić M, Obrenović R. (2011) The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome. Acta Physiol Hung 98(1):91-7. 75.	Milovanovic B, Trifunovic D, Djuric D. (2011) Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril. Acta Physiol Hung. 98(1):71-84. 76.	Rašić-Marković A, Hrnčić D, Djurić D, Macut D, Lončar-Stevanović H, Stanojlović O. (2011) The effect of N-methyl-D-aspartate receptor antagonists on D,L-homocysteine thiolactone induced seizures in adult rats. Acta Physiol Hung 98(1):17-26. 77.	Jakovljević VLj, Zlatković M, Cubrilo D, Pantić I, Djurić DM. (2011) The effects of progressive exercise on cardiovascular function in elite athletes: focus on oxidative stress. Acta Physiol Hung 98(1):51-8. 78.	Djordjevic D, Cubrilo D, Macura M, Barudzic N, Djuric D, Jakovljevic V. (2011) The influence of training status on oxidative stress in young male handball players. Mol Cell Biochem 351(1-2):251-9. 79.	Hrnčić D, Rašić-Marković A, Djuric D, Sušić V, Stanojlović O. (2011) The role of nitric oxide in convulsions induced by lindane in rats. Food Chem Toxicol 49(4):947-54. 80.	Hrncić D, Rasić-Marković A, Krstić D, Macut D, Djuric D, Stanojlović O. (2010) The role of nitric oxide in homocysteine thiolactone-induced seizures in adult rats. Cell Mol Neurobiol 30(2):219-31. 81.	Mladenović D, Djuric D, Petronijević N, Radosavljević T, Radonjić N, Matić D, Hrncić D, Rasić-Marković A, Vucević D, Dekanski D, Stanojlović O. (2010) The correlation between lipid peroxidation in different brain regions and the severity of lindane-induced seizures in rats. Mol Cell Biochem 333(1-2):243-50. 82.	Savic M, Jakovljevic V, Nikolic D, Djuric D. (2009) Evaluation of cerebrovascular insult types and their localization in patients due to the presence of elevated body temperature. Bratisl Lek Listy 110(6):332-4. 83.	Rasić-Marković A, Stanojlović O, Hrncić D, Krstić D, Colović M, Susić V, Radosavljević T, Djuric D. (2009) The activity of erythrocyte and brain Na+/K+ and Mg2+-ATPases in rats subjected to acute homocysteine and homocysteine thiolactone administration. Mol Cell Biochem 327(1-2):39-45. 84.	Radosavljević T, Mladenović D, Jakovljević V, Vucević D, Rasć-Marković A, Hrncić D, Djuric D, Stanojlović O. (2009) Oxidative stress in liver and red blood cells in acute lindane toxicity in rats. Hum Exp Toxicol 28(12):747-57. 85.	Hrncić D, Rasić-Marković A, Susić V, Djurić D, Stanojlović O. (2009) Influence of NR2B-selective NMDA antagonist on lindane-induced seizures in rats. Pharmacology 84(4):234-9. 86.	Milovanovic B, Milinic N, Trifunovic D, Krotin M, Filipovic B, Bisenic V, Djuric D. (2009) Autonomic dysfunction in alcoholic cirrhosis and its relation to sudden cardiac death risk predictors. Gen Physiol Biophys 28 Spec No:251-61. 87.	Rasić-Milutinović Z, Perunicić-Peković G, Ristić-Medić D, Popović T, Glibetić M, Djurić DM. (2009) Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis. Gen Physiol Biophys 28 Spec No:184-9. 88.	Novokmet S, Jakovljevic VLj, Jankovic S, Davidovic G, Andjelkovic N, Milanovic Z, Djuric DM. (2009) Human platelets perfusion through isolated guinea-pig heart: the effects on coronary flow and oxidative stress markers. Gen Physiol Biophys 28 Spec No:98-104. 89.	Stevanovic D, Zhang D, Blumenstein A, Djuric D, Heinle H. (2009) Effects of hydroperoxides on contractile reactivity and free radical production of porcine brain arteries. Gen Physiol Biophys 28 Spec No:93-7. 90.	Rasić-Marković A, Djuric D, Hrncić D, Loncar-Stevanović H, Vucević D, Mladenović D, Brkić P, Djuro M, Stanojević I, Stanojlović O. (2009) High dose of ethanol decreases total spectral power density in seizures induced by D,L-homocysteine thiolactone in adult rats. Gen Physiol Biophys 28 Spec No:25-32. 91.	Vucević D, Petronijević N, Radonjić N, Rasić-Marković A, Mladenović D, Radosavljević T, Hrncić D, Djurić D, Susić V, Djuro M, Stanojlović O. (2009) Acetylcholinesterase as a potential target of acute neurotoxic effects of lindane in rats. Gen Physiol Biophys 28 Spec No:18-24. 92.	Stanojlović O, Rasić-Marković A, Hrncić D, Susić V, Macut D, Radosavljević T, Djuric D. (2009) Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study. Cell Mol Neurobiol 29(3):329-39. 93.	Vucević D, Hrncić D, Radosavljević T, Mladenović D, Rasić-Marković A, Loncar-Stevanović H, Djurić D, Macut D, Susić V, Stanojlović O. (2008) Correlation between electrocorticographic and motor phenomena in lindane-induced experimental epilepsy in rats. Can J Physiol Pharmacol 86(4):173-9. 94.	Mladenović D, Hrncić D, Radosavljević T, Vucević D, Djurić D, Rasić-Marković A, Macut D, Susić V, Sćepanović L, Stanojlović O. (2008) Dose-dependent anticonvulsive effect of ethanol on lindane-induced seizures in rats. Can J Physiol Pharmacol 86(4):148-52. 95.	Radosavljević T, Mladenović D, Vucević D, Petrović J, Hrncić D, Djuric D, Loncar-Stevanović H, Stanojlović O. (2008) Effect of acute lindane and alcohol intoxication on serum concentration of enzymes and fatty acids in rats. Food Chem Toxicol 46(5):1739-43. 96.	Rasić-Marković A, Krstić D, Vujović Z, Jakovljevic V, Stanojlović O, Hrncić D, Djurić D, Loncar-Stevanović H. (2008) Modulations of rabbit erythrocyte ATPase activities induced by in vitro and in vivo exposure to ethanol. Mol Cell Biochem 308(1-2):111-6. 97.	Krstić D, Colović M, Krinulović K, Djurić D, Vasić V. (2007) Inhibition of AChE by single and simultaneous exposure to malathion and its degradation products. Gen Physiol Biophys 26(4):247-53. 98.	Mladenović D, Hrncić D, Vucević D, Radosavljević T, Loncar-Stevanović H, Petrović J, Susic V, Djuric D, Stanojlović O. (2007) Ethanol suppressed seizures in lindane-treated rats. Electroencephalographic and behavioral studies. J Physiol Pharmacol 58(4):641-56. 99.	Hrncić D, Vucević D, Rasić A, Radosavljević T, Mladenović D, Susić V, Djurić D, Stanojlović O. (2007) Moderate body hypothermia alleviates behavioral and EEG manifestations of audiogenic seizures in metaphit-treated rats. Can J Physiol Pharmacol 85(10):1032-7. 100.	Stanojlović O, Hrncić D, Rasić A, Loncar-Stevanović H, Djuric D, Susić V. (2007) Interaction of delta sleep-inducing peptide and valproate on metaphit audiogenic seizure model in rats. Cell Mol Neurobiol 27(7):923-32. 101.	Djuric D, Vusanovic A, Jakovljevic V. (2007) The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart. Molecular and Cellular Biochemistry 300: 177-183. 102.	Jakovljevic VLj, Djuric DM. (2005) The effects of nitric oxide synthase - versus lipoxygenase inhibition on coronary flow and nitrite outflow in isolated rat heart. General Physiology and Biophysics 24: 199-207. 103.	Djuric D, Mitrovic V, Jakovljevic V. (2002) The effects of calcium channel antagonists on coronary nitrite in isolated rat heart. Arzneimittel-Forschung-Drug Research 52: 365-370. 104.	Mitrovic V, Djuric D, Petkovic D, Hamm C. (2002) Evaluation of plasma total homocysteine in patients with angiographically confirmed coronary atherosclerosis: possible impact on therapy and prognosis. Perfusion Verlag 15: 10-19. 105.	Djurich D, Stefanovich E, Tasich N, Yakovlevich V, Kanyukh V, Boijich M. (2000) The use of brachial artery reactivity tests for assessment of endothelial dysfunction in the process of aging. Kardiologiya 11: 24-27. 106.	Jakovljevic VL, Kostic MM, Mujovic VM, Bojic M, Nedeljkovic I, Nedeljkovic TI., Djuric DM. (1999) Interaction between L-arginine, NO system and cyclooxygenase metabolic products of arachidonic acid in coronary autoregulation. Journal of Physiology and Pharmacology 50: 63-74. 107.	Djuric D, Wisotzki R, Mitrovic V. (1999) Rolle von Homocystein bei Atherosklerose-Ist Homocystein ein neuer kardiovaskularer Risikofaktor? Herz Kreislauf 31: 485-490. 108.	Djuric D, Popovic Z, Petrovic J, Bojic M. (1999) Age-related progressive brachial artery endothelial dysfunction precedes the changed carotid and left ventricular geometry in healthy humans. Angiology 50: 555-561. 109.	Plecas B, Glavaski A, Savic V, Hristic M, Djuric D, Solarovic T. (1997) Effects of ethane dimethanesulfonate on the structure of adult male rat adrenal cortex. Pharmacological Research 35: 541-546. 110.	Djuric D, Nesic M, Andjelkovic I. (1996) Endothelium-dependent relaxation of rat aorta to a histamine H3-agonist is reduced by inhibitors of nitric oxide synthase, guanylate cyclase and Na+,K+-ATP-ase. Mediators of Inflammation 5: 69-74. 111.	Djuric D, Andjelkovic I. (1995) The evidence for histamine H3 receptor-mediated endothelium-dependent relaxation in isolated rat aorta. Mediators of Inflammation 4: 217-221. 112.	Djuric MD, Andjelkovic ZI, Rosic A.M. (1993) Effects of methylated derivatives of histamine on the isolated guinea pig aorta. Acta Veterinaria 43: 287-294. 113.	Rosic M, Collis CS, Anjelkovic IZ, Segal MB, Djuric D, Zlokovic BV. (1991) The effects of (R) alpha-methyl histamine on the isolated guinea pig aorta. Agents Actions Suppl 33: 283-287. 114.	Djuric D, Jovanovic T, Andjelkovic I. (1989) Does hyperthyroidism change the reactivity of canine endothelium-intact pulmonary artery strips to catecholamines and prostaglandins? Iugoslavica Physiologica et Pharmacologica Acta 25: 249-253. 115.	Jovanovic T, Djuric D, Stevanovic H. (1988) The influence of hyperthyroidism on pulmonary and systemic venous smooth muscle reactivity. Periodicum Biologorum 90: 363-366. EDITORIALS AND REPORTS PUBLISHED IN JOURNALS INDEXED IN CURRENT CONTENTS, SCIENCE CITATION INDEX OR SCIENCE CITATION INDEX EXPANDED 116.	Djuric DM. Editorial: Sulfur-Containing Amino Acids in Cardiovascular and Neural Physiology, Pathophysiology and Pharmacology: An Overview and Update. Curr Med Chem. 2018 Jan 30;25(3):322-323. doi: 10.2174/092986732503180130142900. 117.	Djuric D, Dhalla N, Jakovljevic V. (2016) Preface. Can J Physiol Pharmacol. 2016 Oct;94(10):v. 118.	Djuric DM. Third Congress of Physiological Sciences of Serbia with international participation (October 29-31, 2014, Belgrade, Serbia) (Report). Acta Physiol Hung. 2015 Jun;102(2):123-4. 119.	Djuric DM. (2012) Editorial: preclinical testing of active substances and cancer research. Med Chem 1;8(1):1. 120.	Djuric D. (2010) Second Congress of Physiological Sciences of Serbia with international participation. Acta Physiol Hung 97(1):57-8. 121.	Djurić DM. (2009) Professor Richard Burian (1871-1954), founder of the Institute of Medical Physiology, School of Medicine, University of Belgrade. Gen Physiol Biophys 28 Spec No:5-8. 122.	Djurić DM. (2008) Preface. Bridging the gap: where progress in cardiovascular and neurophysiologic research meet. Can J Physiol Pharmacol 86(4):138.

matches: V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V. V.


D.C. Law Library - § 1–309.13. Advisory Neighborhood Commissions — Funds; audit of accounts; employees; financial reports; publications.
↪ § 1–309.13. Advisory Neighborhood Commissions — Funds; audit of accounts; employees; financial reports; publications.
§ 1–309.12. Advisory Neighborhood Commissions — Joint meetings; involvement of neighborhood groups; service area coordinators; service area manager; citizen’s advisory mechanism.
§ 1–309.13. Advisory Neighborhood Commissions — Funds; audit of accounts; employees; financial reports; publications.
(a) Each Commission shall receive an annual allocation pursuant to § 1-207.38 to be distributed quarterly during the fiscal year, except that if the District’s appropriations act for the fiscal year has not become effective at the beginning of the fiscal year, each Commission shall receive its first quarterly allocation for the fiscal year if and when a continuing resolution is adopted by the Congress of the United States.
(b)(1) Each Commission shall by resolution designate a commercial bank, savings and loan association, credit union, or any combination thereof, which is insured by the government of the United States pursuant to 12 U.S.C. § 1811 et seq. and which is located within the District of Columbia, as a depository of all funds received by the Commission.
(2) Each Commission shall request a District of Columbia Tax Identification Number and include the phrase “District of Columbia Government” in each account name within 90 days after June 27, 2000.
(3) Each Commission shall establish no more than one checking or negotiable order of withdrawal account. The Commission may deposit into any savings account created pursuant to this section funds not immediately needed for the operation of the Commission.
(b-1)(1) Each Commission may obtain one debit card associated with the Commission's checking account.
(2) Each Commission that obtains a debit card shall do so according to a procedure determined by the OANC that limits monthly debit card expenditures relative to the Commission's quarterly allotment.
(c) The treasurer of each Commission shall file with the Office of the District of Columbia Auditor (“Auditor”), within 30 days of assuming the office of treasurer or within 30 days of any change in the requested information, on a form provided by the Auditor, a statement that includes the treasurer’s name, home and business address and telephone number, the location of the books and records of the Commission and the name and location of any depository of the Commission’s funds, including account numbers. The treasurer and Chairperson shall file with the Auditor and maintain in force during their occupancy of their respective offices, a cash or surety bond in an amount and on a form satisfactory to the Auditor. Participation by a Commission in the Advisory Neighborhood Commission Security Fund established by § 1-309.14 shall satisfy the requirement of a cash or surety bond. The bylaws adopted by each Commission shall include a provision for filling in a timely manner a vacancy in the office of treasurer from among the remaining Commissioners. No expenditure shall be made by a Commission during a vacancy in the office of treasurer or at any time when a current and accurate statement and bond or its equivalent are not on file with the Auditor.
(c-1) The treasurer of each Commission shall maintain an up-to-date treasurer's report that shall be available for any Commissioner or member of the public to review at each regular public Commission meeting.
(d)(1) The Auditor shall audit the financial accounts of selected Commissions and maintain a database of financial information of each Commission for historical and expenditure trend analysis. The Auditor shall produce and submit to the Council a consolidated annual report of the financial activity of all the Commissions.
(2) The Auditor may audit the financial accounts of a Commission, at the discretion of the Auditor, upon the request by a member of the Council or a Commissioner of the Commission for which an audit is requested. The findings and recommendations of any audit shall be forwarded to the affected Commission, the Council, the Mayor, the Office of Advisory Neighborhood Commissions, the Office of the Inspector General, the Office of the Attorney General for the District of Columbia, and any other law enforcement agency with jurisdiction over alleged improper conduct.
(3) In a case in which an Auditor’s report details a violation of this part, the affected Commission shall, within 90 days, provide in writing to the Auditor, its response to each of the alleged infractions. If the audited Commission fails to respond within 90 days, its next scheduled quarterly allotments shall be forfeited until the response has been filed.
(e) Each Commission shall, by resolution, designate the location at which the Commission’s books and records shall be maintained which shall, if the Commission has a regular office, be the Commission office. The Auditor shall have access to the books and records of each Commission pursuant to § 1-204.55(c), and may issue subpoenas to banking and financial institutions requiring the production of financial documents and statements pursuant to an audit conducted under this part. Such financial documents shall include, but not be limited to, bank statements, canceled checks, and signature cards. The Auditor may apply to the Superior Court of the District of Columbia for an order enforcing the subpoena. Any failure to obey the order of the court may be punished by the Superior Court as civil contempt.
(f)(1) Any expenditure of funds by a Commission shall be recorded by the treasurer in the Commission’s books of accounts. No expenditure of any amount shall be made without the specific authorization of the Commission, except for reimbursements approved by the Commission treasurer under subsection (l-1) of this section. The depository in which the Commission maintains a checking account shall be immediately notified of any change in Commission officers.
(iv) Bear the name of the Commission and “District of Columbia Government” on its face.
(iv) A note describing the purpose of the payment.
(C) No check may be made payable to cash.
(ii) Conducted according to a procedure determined by the OANC.
(B) The Treasurer shall retain written documentation of authorizations, which shall bear the signatures of the 2 officers who authorized the expenditure pursuant to subparagraph (A)(ii) of this paragraph.
(3) A Commission may provide reimbursement for an authorized purchase made with a personal credit card, debit card, or cashier’s check that is documented with a receipt, a copy of which shall be submitted to the Commission.
(g) Disbursements of Commission funds exceeding $50 for personal service expenditures shall be specifically approved by the Commission at a public meeting prior to the disbursement. The approval shall be recorded in the minutes of the Commission meeting. Any personal services payment shall name the person who is to receive the payments, the rate of compensation, and the maximum hours of service, if less than full-time compensation. If an expenditure is made without the required authorization of the Commission, the expenditure shall be deemed to be a personal expense of the Commissioner who authorized the payment, unless the Commission subsequently approves the expenditure within 90 days. If the Commission fails to approve the expense within 90 days, the Office of the Attorney General for the District of Columbia, upon notification by the OANC, shall institute any actions necessary to recover Commission funds.
(h) Each Commission may establish a petty cash fund not to exceed $200 at any one time in accordance with procedures established for imprest funds by the D.C. Controller. The fund shall be reimbursed by the treasurer upon presentation of appropriate supporting documents. The treasurer may disburse to another Commissioner or employee of the Commission an amount not in excess of $200 for authorized Commission expenditures through a Commission-established petty cash fund. A record of disbursements from the petty cash fund shall be kept by the treasurer in a manner consistent with other accounts of the Commission.
(i) A Commission shall maintain its accounts on a fiscal year basis beginning October 1 and ending the following September 30.
(j)(1) The treasurer of a Commission shall prepare a quarterly financial report on a form provided by the OANC. The financial report shall be presented to the Commission for its consideration at a Commission meeting within 45 days after the end of the quarter. A copy of the approved financial report, signed by the Chairperson, the secretary, and the treasurer, shall be filed, along with a record of the vote adopting the report, with the OANC within 15 days of approval. Each quarterly report shall include copies of canceled checks, bank statements, grant request letters and grant disbursements, invoices and receipts, executed contracts, details about all contributions received during the time period covered by the quarterly report, the minutes of all meetings indicating the Commission’s approval of disbursements during the time period covered by the quarterly report, and certification of the Commission’s approval of the quarterly report signed by the Commission’s Secretary. The Commission shall make available for on-site review to the OANC, upon the OANC’s request, originals of documents required to be submitted with quarterly financial reports pursuant to this section. A financial report shall be available for public inspection during the normal office hours of the Commission.
(2) No quarterly allotment shall be forwarded to a Commission until all reports of financial activity for the quarters preceding the immediate previous quarter are approved by the OANC. If a Commission fails to file 3 consecutive quarterly reports that meet the requirements of paragraph (1) of this subsection, it shall relinquish its checkbook and access to its debit card to the OANC, whose permission will be needed for any expenditure made by check or debit card until the Commission files the required financial reports. Upon receiving and approving all outstanding quarterly financial reports from the Commission, the OANC shall immediately return the checkbook and access to the debit card to the Commission. The Mayor, upon the request of the OANC, may issue official instructions to any pertinent banking institution to freeze accounts held by a Commission that has not complied with this paragraph.
(3) If, on the last day of the fiscal year, a Commission has not received a quarterly allotment because it failed to file a quarterly report approved by the OANC, the Commission shall forfeit the unclaimed allotment or allotments and the funds shall be returned to the District’s General Fund.
(l)(1) A Commission shall expend funds received through the annual allocation received pursuant to subsection (a) of this section, or other donated funds, for public purposes within the Commission area or for the functioning of the Commission office, including staff salaries, Commissioner training, property liability insurance, legal expenses for Commission representation by an attorney licensed in the District before an agency, board, or commission of the District government, and nominal refreshments at Commission meetings. Nominal refreshments shall be limited to $100 worth of food and nonalcoholic beverages per regular public Commission meeting, and any refreshments purchased shall be available to the public. Expenditures may be in the form of grants by the Commission for public purposes within the Commission area pursuant to subsection (m) of this section. A public purpose shall be a purpose that benefits the community as a whole and is not done for the primary purpose of benefitting a private entity. A Commission may expend its funds for Commissioner training on subjects pertaining to their official duties when such training is not available from government sources. A Commission may expend its funds to purchase insurance or obtain indemnification against any loss in connection with the assets of the Commission or any liability in connection with the activities of the Commission, such insurance or indemnification to be purchased or obtained in such amounts and from such sources as the Commission deems to be appropriate. Funds may be used to pay the local transportation expenses of a Commissioner if the Commissioner is officially representing the Commission or a committee of the Commission at public hearings or meetings or is engaged in official Commission business. Where a Commissioner submits a complete and valid application for reimbursement for travel or childcare expenses under subsection (l-1) of this section, a Commission shall reimburse that Commissioner for all requested expenses for which the Commissioner qualifies under subsection (l-1).
(2) No Commission may expend funds except as authorized under this part. Prohibited expenditures include those for any purpose that involves partisan political activity, legal expenses other than for Commission representation before an agency, board, or commission of the District government, or travel outside of the Washington metropolitan area.
(3) Commissions shall use staff payroll forms provided by the OANC.
(l-1)(1) A Commission shall expend funds to reimburse any Commissioner who submits a complete application for reimbursement from the Commission allotment for qualifying travel or childcare expenses incurred to carry out qualifying official duties of the Commissioner in accordance with this subsection; provided, that the maximum total reimbursement that any individual Commissioner may receive under this subsection in a single calendar year shall be $500.
(2) An application for reimbursement shall be completed using a form created by the OANC, which shall be available to individual Commissioners upon request, and which shall indicate any attachments required to demonstrate that the expense qualifies under this subsection. A Commission Treasurer shall not approve the release of Commission funds under this subsection except where the application for reimbursement meets all requirements under this subsection. To qualify for reimbursement under this subsection, a Commissioner shall submit an application within 30 days of incurring the relevant expense. Upon approving an application for reimbursement under this subsection, the Commission Treasurer shall electronically transmit the application to the OANC, which shall maintain electronic copies of all applications. The Commission Treasurer shall ensure that applications submitted under this subsection are included in quarterly financial reports of the Commission prepared pursuant to subsection (j) of this section.
(v) Attending training provided under this part.
(ii) Expenses charged to the Commissioner for childcare services that comply with all licensing requirements of the Office of the State Superintendent of Education.
(4) Notwithstanding this subsection, the OANC may approve Commission reimbursements to Commissioners for local transportation expenses, other than qualifying travel expenses, pursuant to subsection (l)(1) of this section.
(m)(1) A grant may not be awarded unless the grant is awarded pursuant to a vote of the Commission at a public meeting following the public presentation of the grant request. A Commission may approve grants only to organizations that are public in nature and benefit persons who reside or work within the Commission area. The services provided by the grantee organization must not be duplicative of any that are already performed by the District government.
(D) An accounting by the grantees of the expected overhead costs the grantees will incur in carrying out the grant. No Commission shall provide a grant for which the grantee estimates that the overhead costs would exceed 15% of the entire grant amount.
(B) Shall maintain a list, available to any Commissioner upon request, of prohibited grantees identified pursuant to subparagraph (A) of this paragraph.
(4) Grant disbursements shall be included in quarterly financial reports submitted to the OANC.
(n) The Mayor may, pursuant to subchapter I of Chapter 5 of Title 2, issue rules to implement the provisions of this section. The proposed rules shall be submitted to the Council for a 45-day period of review, excluding Saturdays, Sundays, legal holidays, and days of Council recess. If the Council does not approve or disapprove the proposed rules, in whole or in part, by resolution within this 45-day review period, the proposed rules shall be deemed approved.
(o) A Commission may employ any person necessary to provide administrative support to the Commission. A Commission shall establish position descriptions for employees that shall, at a minimum, broadly identify the qualifications and duties of the employees. A Commission employee shall serve at the pleasure of the Commission. An employee of the Commission shall be considered an employee of the District of Columbia government for the purposes of subchapters XXI, XXII, and XXIII of Chapter 6 of Title 1. Except for out of pocket expenses approved by the Commission, Commissioners shall not be compensated for personal services rendered on behalf of the Commission.
(p) Any Commissioner within an individual Commission shall have equal access to the Commission office and its records in order to carry out Commission duties and responsibilities. Moreover, any person has a right to inspect, and at his or her discretion, to copy any public record of the Commission, except as otherwise expressly provided by § 2-534, in accordance with reasonable procedures that shall be issued by the Commission after notice and comment concerning the time and place of access.
(q) Upon the request of a Commission, evidenced by a properly adopted resolution signed or transmitted by the Chairperson and secretary, the Mayor shall provide that Commission with suitable office space in a District-owned or leased building. The Mayor shall acknowledge receipt of the resolution within 15 days and shall provide the Commission with a list of available office space within 45 days thereafter. The space shall be a minimum of 250 square feet and shall be the sole office of the Commission. The space shall be located within the Commission’s boundaries. If no such space is available, then the space shall be located within the ward boundaries of the Commission. If District-owned or leased office space cannot be provided, the Mayor shall assist the Commission in locating appropriate office space in the ward in which the Commission is located, and may seek to reprogram funds up to $600 per month to cover the rental of office space for the respective Commission. Furnishings, equipment, telephone service, and supplies for the office space shall be provided from the Commission’s funds. There shall be a written lease between the Mayor or District agency and the Commission, which shall specify what operating costs, such as utilities, janitorial services, and security, shall be paid by the Commission.
(r) Any document created by requirement of this part, and any equipment purchased by, or on behalf of, a Commission, is the property of the District, and not the property of any Commissioner or other individual.
(s) Commissioners shall attend at least one training session per year conducted by the OANC pursuant to § 1-309.15(c)(5).
(t) For the purposes of this section, the term "debit card" means a card issued by a bank allowing the cardholder to draw funds from a specific account, established at that bank, that does not allow for any funds to be borrowed from the issuing bank.
This section is referenced in § 1-309.10, § 1-309.11, and § 1-309.12.
“(b) Each Commission shall by resolution designate a commercial bank, savings and loan association, credit union, or any combination thereof, which is insured by the government of the United States pursuant to the Federal Deposit Insurance Act, approved September 21, 1950 (87 Stat. 873; 12 U.S.C. 1811 et seq.), and which is located within the District of Columbia, as a depository of all funds received by the Commission. Each Commission shall establish no more than one checking or negotiable order of withdrawal account. The Commission may deposit into any savings account created pursuant to this section funds not immediately needed for the operation of the Commission.
“(c) The treasurer of each Commission shall file with the Office of the District of Columbia Auditor, within 30 days of assuming the office of treasurer or within 30 days of any change in the requested information, on a form provided by the Auditor, a statement that includes the treasurer’s name, home and business address and telephone number, the location of the books and records of the Commission and the name and location of any depository of the Commission’s funds, including account numbers. The treasurer shall file with the District of Columbia Auditor and maintain in force during the treasurer’s occupancy of the office a cash or surety bond in an amount and on a form satisfactory to the Auditor. Participation by a Commission in the Advisory Neighborhood Commission Security Fund established by § 1-264.1 shall satisfy the requirement of a cash or surety bond. The bylaws adopted by each Commission shall include a provision for filling in a timely manner a vacancy in the office of treasurer from among the remaining Commissioners. No expenditure shall be made by a Commission during a vacancy in the office of treasurer or at any time when a current and accurate statement and bond or its equivalent are not on file with the District of Columbia Auditor.
“(d) The District of Columbia Auditor shall audit the financial accounts of selected Commissions and maintain a database of financial information of each Commission for historical and expenditure trend analysis. The Auditor shall produce and submit to the Council a consolidated annual report of the financial activity of all the Commissions. The Auditor may audit the financial accounts of a Commission, at the discretion of the Auditor, upon the request by a member of the Council or a Commissioner of the Commission for which an audit is requested.
“(e) Each Commission shall, by resolution, designate the location at which the Commission’s books and records shall be maintained which shall, if the Commission has a regular office, be the Commission office. The District of Columbia Auditor shall have access to the books and records of each Commission pursuant to § 47-117(c), and may issue subpoenas to banking and financial institutions requiring the production of financial documents and statements pursuant to an audit conducted under §§ 1-252 through 1-264.1. Such financial documents shall include, but not be limited to, bank statements, cancelled checks, and signature cards. The District of Columbia Auditor may apply to the Superior Court of the District of Columbia for an order enforcing the subpoena. Any failure to obey the order of the court may be punished by the Superior Court as civil contempt.
“(f) Any expenditure of funds by a Commission shall be authorized in writing by the treasurer or Chairman and recorded by the treasurer in the Commission’s books of accounts. No expenditure of any amount shall be made without the specific authorization of the Commission. Any expenditure made by check shall be signed by at least 2 officers of the Commission, one of whom shall be the treasurer or Chairman. The check shall, prior to signature, contain the date of payment, the name of the payee, and the amount of the payment. No check may be made payable to cash. Any check shall be pre-numbered, shall bear the name of the Commission on its face, and shall be issued in consecutive order. The depository in which the Commission maintains a checking account shall be immediately notified of any change in Commission officers.
“(g) Disbursements of Commission funds exceeding $50 for personal service expenditures shall be specifically approved by the Commission at a public meeting prior to the disbursement. The approval shall be recorded in the minutes of the Commission meeting. Any personal services payment shall name the person who is to receive the payments, the rate of compensation, and the maximum hours of service, if less than full-time compensation. If an expenditure required to be approved pursuant to this subsection is made without the required authorization of the Commission, the expenditure shall be deemed to be a personal expense of the officer who authorized the payment, unless the Commission subsequently approves the expenditure.
“(h) Each Commission may establish a petty cash fund not to exceed $50 at any one time in accordance with procedures established for imprest funds by the D.C. Controller. The fund shall be reimbursed by the treasurer upon presentation of appropriate supporting documents. The treasurer may disburse to another Commission member or employee of the Commission an amount not in excess of $50 for authorized Commission expenditures through a Commission-established petty cash fund. A record of disbursements from the petty cash fund shall be kept by the treasurer in a manner consistent with other accounts of the Commission.
“(i) A Commission shall maintain its accounts on a fiscal year basis beginning October 1 and ending the following September 30.
“(j)(1) The treasurer of a Commission shall prepare a quarterly financial report on a form provided by the Auditor. The financial report shall be presented to the Commission for its consideration at a public meeting of the Commission within 30 days of the end of the quarter. A copy of the approved financial report, signed by the Chairman, the secretary, and the treasurer, shall be filed, along with a record of the vote adopting the report, with the District of Columbia Auditor within 7 days of approval. A financial report shall be available for public inspection during the normal office hours of the Commission.
“(2) No quarterly allotment shall be forwarded to a Commission until all reports of financial activity for the quarters preceding the immediate previous quarter are approved by the Auditor.
“(3) If, on the last day of the fiscal year, a Commission has not received a quarterly allotment because it failed to file a quarterly report approved by the Auditor, the Commission shall forfeit the unclaimed allotment or allotments and the funds shall return to the District’s General Fund.
“(4) This subsection shall take effect beginning in fiscal year 1999.
“(k) Commissions may pool Commission funds in accordance with agreements adopted by their constituent Commissions.
“(l) A Commission shall expend funds received through the annual allocation received pursuant to subsection (a) of this section, or other donated funds, for public purposes within the Commission area or for the functioning of the Commission office, including staff salaries and nominal refreshments at Commission meetings. A Commission may expend its funds for public purposes outside of the Commission area as authorized pursuant to subsection (k) of this section. Expenditures may be in the form of grants by the Commission for public purposes within the Commission area pursuant to subsection (m) of this section. Funds allocated to the Commissions may not be used for a purpose that involves partisan political activity, personal subsistence expenses, Commissioner compensation, meals, legal expenses other than for Commission representation before an agency, board, or commission of the District government, or travel outside of the Washington metropolitan area. Funds may be used to pay the local transportation expenses of a Commissioner if the Commissioner is officially representing the Commission or a committee of the Commission at public hearings or meetings or is engaged in official Commission business.
“(m) A grant approved by a Commission shall provide a benefit that is public in nature and that benefits persons who reside or work within the Commission area. A grant to an individual shall be prohibited as a non-public purpose expenditure. A Commission shall adopt guidelines for the consideration and award of grants that shall include a provision that requires the proposed grantee to present the request for a grant at a public meeting of the Commission. A grant may not be awarded unless the grant is awarded pursuant to a vote of the Commission at a public meeting. The award of a grant by a Commission shall not be conditioned on support for a position taken by the Commission.
“(n) The Mayor may, pursuant to subchapter I of Chapter 15 of Title 1, issue rules to implement the provisions of this section. The proposed rules shall be submitted to the Council for a 45-day period of review, excluding Saturdays, Sundays, legal holidays, and days of Council recess. If the Council does not approve or disapprove the proposed rules, in whole or in part, by resolution within this 45-day review period, the proposed rules shall be deemed approved.
“(o) A Commission may employ any person necessary to provide administrative support to the Commission. A Commission shall establish position descriptions for employees that shall, at a minimum, broadly identify the qualifications and duties of the employees. A Commission employee shall serve at the pleasure of the Commission. An employee of the Commission shall be considered an employee of the District of Columbia government for the purposes of subchapters XXII and XXIII of Chapter 6 of this title.
“(p) Any Commissioner within an individual Commission shall have equal access to the Commission office in order to carry out Commission duties and responsibilities.
Criminal justice supervisory board, promulgation of rules of procedure, see § 3-904.
Section 7036 of D.C. Law 22-33 amended § 3 of D.C. Law 21-269 to repeal the delayed applicability provision. Therefore the changes made to this section by D.C. Law 21-269 have been given effect.
Applicability of D.C. Law 21-269: § 3 of D.C. Law 21-269 provided that the change made to this section by § 2(h)(10) of D.C. Law 21-269 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
For temporary (90 days) amendment of this section, see § 1062 of Fiscal Year 2019 Budget Support Congressional Review Emergency Act of 2018 (D.C. Act 22-458, Oct. 3, 2018, 65 DCR 11212).
For temporary (90 days) amendment of this section, see § 1062 of Fiscal Year 2019 Budget Support Emergency Act of 2018 (D.C. Act 22-434, July 30, 2018, 65 DCR 8200).
For temporary (90 days) amendment of this section, see § 2(c) of Advisory Neighborhood Commissions Transfer Authorization Emergency Amendment Act of 2017 (D.C. Act 22-35, Mar. 28, 2017, 64 DCR 3103).
For temporary (90 day) amendment of section, see § 401 of the Fiscal Year 1997 Budget Support Congressional Adjournment Emergency Amendment Act of 1997 (D.C. Act 12-2, February 19, 1997, 44 DCR 1590).
For temporary (90 day) amendment of section, see § 1302 of the Fiscal Year 1999 Budget Support Emergency Act of 1998 (D.C. Act 12-401, July 13, 1998, 45 DCR 4794) and § 1302 of the Fiscal Year 1999 Budget Support Congressional Review Emergency Act of 1998 (D.C. Act 12-564, January 12, 1999, 46 DCR 669).
For temporary (90 day) amendment of section, see § 2 of the Advisory Neighborhood Commissions Management Control and Funding Emergency Amendment Act of 1998 (D.C. Act 12-619, January 22, 1999, 46 DCR 1339).
For temporary (90-day) amendment of section, see § 1302 of the Fiscal Year 1999 Budget Support Congressional Review Emergency Act of 1999 (D.C. Act 13-41, March 31, 1999, 46 DCR 3446).
For temporary (90-day) amendment of section, see § 2 of the Advisory Neighborhood Commissions Management Control and Funding Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-67, May 10, 1999, 46 DCR 4471).
For temporary (90-day) amendment of section, see § 2 of the Advisory Neighborhood Commissions Management Control Emergency Amendment Act of 1999 (D.C. Act 13-207, December 8, 1999, 46 DCR 10470).
For temporary (90-day) amendment of section, see § 2 of the Advisory Neighborhood Commissions Management Control Congressional Review Emergency Amendment Act of 2000 (D.C. Act 13-317, April 17, 2000, 47 DCR 2877).
For temporary (90 day) amendment of section, see § 2(a) of Advisory Neighborhood Commission Emergency Amendment Act of 2001 (D.C. Act 14-56, May 2, 2001, 48 DCR 4410).
For temporary (90 day) amendment of section, see § 2(a) of Advisory Neighborhood Commission Congressional Review Emergency Amendment Act of 2001 (D.C. Act 14-104, July 23, 2001, 48 DCR 7149).
For temporary (90 day) amendment of section, see § 2 of Advisory Neighborhood Commissions Clarification Congressional Review Emergency Amendment Act of 2006 (D.C. Act 16-577, December 19, 2006, 54 DCR 33).
For temporary (90 day) amendment of section, see § 2 of Advisory Neighborhood Commissions Clarification Emergency Amendment Act of 2007 (D.C. Act 17-157, October 18, 2007, 54 DCR 10924).
For temporary (90 day) amendment of section, see § 2 of Advisory Neighborhood Commissions Clarification Congressional Review Emergency Amendment Act of 2008 (D.C. Act 17-248, January 23, 2008, 55 DCR 1253).
For temporary (225 day) amendment of section, see § 401 of Fiscal Year 1997 Budget Support Temporary Amendment Act of 1996 (D.C. Law 11-226, April 9, 1997, law notification 44 DCR 2584).
For temporary (225 day) amendment of section, see § 2 of Advisory Neighborhood Commissions Management Control and Funding Temporary Amendment Act of 1999 (D.C. Law 12-276, April 27, 1999, law notification 46 DCR 4282).
For temporary (225 day) amendment of section, see § 2 of Advisory Neighborhood Commissions Management Control Temporary Amendment Act of 2000 (D.C. Law 13-93, April 12, 2000, law notification 47 DCR 2844).
For temporary (225 day) amendment of section, see § 2(a) of Advisory Neighborhood Commission Temporary Amendment Act of 2001 (D.C. Law 14-21, September 6, 2001, law notification 48 DCR 9091).
Section 4(b) of D.C. Law 16-261 provided that the act shall expire after 225 days of its having taken effect.


text:
From the Save In: Supported Operating Systems Windows You may not use the optical discs or storage media on another computer, device or network, or loan, rent, lease or transfer them to another user except as permitted by this Agreement. Updates, patches or alerts may be delivered from Dell servers, which may be located outside of your country. The use of the program is also subject to the bcm v. Once Windows starts back up, that process should not be running. One big advantage of the BCM V. You may find corresponding source files for the Software at v9.
Replacing cellular modem in Dell Venue 11 Pro If you are a commercial customer of Dell, you hereby grant Dell or an agent selected by Dell the right to perform an audit of your use of the Software during normal business hours; you agree to cooperate with Dell in such audit; and you agree to bcm v.
I installed a telephony modem from Dell. I was wondering about the modem too. You modrm transfer the Software and all accompanying materials on a permanent basis as part of a sale or transfer of the Dell product on which it was preloaded by Dell, where applicable, if you retain no copies bcm v 92 56k modem the recipient agrees to the terms hereof.
This Agreement is binding on successors and assigns. Maybe a better qualified person will see this and reply to you.
Any replacement media is warranted for the remaining original warranty period or 30 days, whichever is longer. Type S — Rev. Except as prohibited by local law, this Agreement is governed by the laws of the State of Texas, without vcm to principles of conflicts of laws. Moden, I do not agree Yes, I agree. Download the latest drivers for your Broadcom Modems to keep your Computer up-to-date. Write down this path so the executable I. Hi, I am running RedHat 9 using kernel 2.
The use of the program is also subject to the terms of your Mode Agreement and Terms and Conditions of Sale if in the Bcm v. Subject to the terms, conditions and limitations of this Agreement, Dell grants you a limited, nonexclusive, nontransferable except bcm v 92 56k modem set forth hereinnonassignable license to use the Software in object code only on as many computers, devices, or in such configurations moodem you are expressly entitled, or on one computer or device if no other entitlement is specified, and for such period as you are entitled, in the case of a term bcm v 92 56k modem, and perpetually, if no term is specified.
Network bck Modems Manufacturer: Sign up for a new account in our community. Do not turn off your computer or disconnect from your power source while updating the BIOS or you may harm your computer.
Dell recommends the customer bcm v 92 56k modem specifics about the update to determine if it applies to your system. You may find corresponding source files for the Software at v9. Can bcm v 92 56k modem check what you ordered? Outdated Network and Modems Drivers? I also have a BCM V. Installing or uninstalling software and making changes to mode system can leave your Windows registry fragmented, with obsolete and harmful files.
Select modem driver installation directory for the appropriate Microsoft Windows operating system and run modem installation program Setup.
You may make one copy of the Software solely for backup or archival purposes, or transfer it to 5k6 single hard disk or storage device provided you keep omdem copy solely bcm v. To disable this process or any non-Windows startup process, for that matterclick Start, then select “Run By StephenJuly 26, in Hardware.
The use of the program is also subject to the bcm v. You are currently viewing the device driver detail page for BCM V. The terms of this Agreement do not entitle morem to any maintenance or support for the Software.
Browse more device drivers BCM V. Find out how to make your computer faster by running our Free Performance Scan.
You may not sublicense, rent, or lease the Software or copy the written materials accompanying the Software. Visit the following links: You may make one copy of the Software solely for backup or archival purposes, or transfer it to a single hard disk or storage device provided you keep the copy solely for backup or archival purposes. Either I didn’t notice it before, or somehow it has activated itself.

matches: v. V. v. v. V. v. v. V. V.


240. Breach of contract is where a party thereto breaks through the obligation which it imposes.
(a) It always gives the party injured a right of action.
(b) It often, but not always, discharges the contract. This depends upon circumstances to be presently discussed.
If one of the parties to a contract breaks through the obligation which it imposes, a new obligation arises in every case - a right of action conferred upon the party injured by the breach. Besides this, there are circumstances under which the breach will discharge the injured party from such performance as may still be due from him. Every breach of contract confers the right of action upon the injured party, but every breach does not necessarily discharge him from doing what he has undertaken to do under the contract. The contract may be broken wholly or in part, and, if in part, the breach may or may not be sufficiently important to operate as a discharge; or, if it is of such importance, the injured party may choose not to regard it as a discharge, preferring to continue to carry out the contract, reserving to himself the right to sue for such damages as he may have sustained by the breach. It is often very difficult to determine whether or not a breach of one of the terms of a contract discharges the party injured.45 These questions will be discussed in the following pages.
Pick. (Mass.) 48; Lindsay v. Matthews, 17 Fla. 575. See Jones, Mortg. § 900. Tender to pledgee of amount secured is not vitiated by condition that pledge be delivered. Loughborough v. McNevin, 74 Cal. 250, 14 Pac. 369, 15 Pac. 773, 5 Am. St. Rep. 435. See "Tender," Dec. Dig. (Key-No.) § 14; Cent. Dig. §§ SS-S8.
40 Waldron v. Murphy, 40 Mich. 668. See "Tender," Dec. Dig. (Key-No.) §§ 8, 9; Cent. Dig. §§ 11-19.
41 Berley & Kyzer v. Columbia, N. & L. R. Co., 82 S. C. 232, 64 S. E. 397. See "Tender," Dec. Dig. (Key-No.) § 8; Cent. Dig. §§ 11, 12.
42 Weinberg v. Naher, 51 Wash. 591, 99 Pac. 736, 22 L. R. A. (N. S.) 956. See "Tender," Dec. Dig. (Key-No.) §§ 4, 5; Cent. Dig. §§ 5-7.
43 Dixon v. Fletcher, 3 Mees. & W. 146; Hart v. Mills, 15 Mees. & W. 85; Curliffe v. Harrison, 6 Exch. 903; Perry v. Iron Co., 16 R. I. 318, 15 Atl. 87; Rommel v. Wingate, 103 Mass. 327; Croninger v. Crocker, 62 N. Y. 151; Tiffany, Sales, 187. See "Sales," Dec. Dig. (Key-No.) § 158; Cent. Dig. §§ S58S66.
44 Isherwood v. Whitmore, 10 Mees. & W. 757; Wyman v. Winslow, 11 Me. 398, 26 Am. Dec. 542; Holmes v. Gregg, 66 N. H. 621, 28 Atl. 17; Tiffany, Sales, 197. See "Sales," Dec. Dig. (Key-No.) § 153; Cent. Dig. §§ 358S66.


text:
The District Court's general finding of guilt in a bench trial is for double jeopardy purposes the same as a jury verdict of guilty. The Government is therefore entitled, pursuant to the Criminal Appeals Act, to appeal the District Court's subsequent order suppressing certain evidence on reconsideration of respondent's pretrial motion, which was originally denied, since success on that appeal would result in reinstatement of the District Court's general finding of guilt, rather than in further factual proceedings relating to guilt or innocence. United States v. Wilson, 420 U.S. 332 .
Respondent was charged with possessing marihuana with intent to distribute in violation of 21 U.S.C. 841 (a) (1). He filed a pretrial motion to suppress the marihuana on [429 U.S. 1, 2] the ground that the search of his car violated the Fourth Amendment. He waived his right to a jury trial. The motion to suppress was heard during the trial on the merits, and the District Court denied the motion to suppress and found the respondent guilty as charged.
Approximately three months later, we held that a warrantless roving patrol search of vehicles for aliens, conducted without probable cause at a point removed from the border or its functional equivalent, violated the Fourth Amendment. Almeida-Sanchez v. United States, 413 U.S. 266 (1973). The Court of Appeals for the Tenth Circuit thereafter held that Almeida-Sanchez should be applied retroactively and that its rationale encompasses searches conducted at fixed traffic checkpoints. United States v. King, 485 F.2d 353 (1973); United States v. Maddox, 485 F.2d 361 (1973).
Thereupon the Government appealed pursuant to 18 U.S.C. 3731. 2 While this appeal was pending in the [429 U.S. 1, 3] Court of Appeals, we held in Bowen v. United States, 422 U.S. 916 (1975); United States v. Peltier, 422 U.S. 531 (1975), that Almeida-Sanchez was not to be applied retroactively to Border Patrol searches conducted prior to June 21, 1973. After the Government moved for summary reversal of the District Court's suppression order, the Court of Appeals, without benefit of briefing or oral argument, dismissed the Government's appeal for lack of jurisdiction, finding that double jeopardy would bar a retrial. The court, citing United States v. Jenkins, 420 U.S. 358 (1975), felt that double jeopardy would bar because further proceedings involving "the resolution of factual issues going to the elements of the offense charged . . ." would be required.
"[W]hen a judge rules in favor of the defendant after a verdict of guilty has been entered by the trier of fact, the Government may appeal from that ruling without running afoul of the Double Jeopardy Clause." Id., at 352-353.
"A general finding of guilt by a judge may be analogized to a verdict of `guilty' returned by a jury." 420 U.S., at 365-366.
Thus the District Court's general finding of guilt here is for double jeopardy purposes the same as a jury verdict of guilty. The Government is therefore entitled to appeal the order suppressing the evidence, since success on that appeal would result in the reinstatement of the general finding of guilt, rather than in further factual proceedings relating to [429 U.S. 1, 4] guilt or innocence. As in Wilson, there would then remain only the imposition of sentence and the entry of a judgment of conviction pursuant to Fed. Rule Crim. Proc. 32.
[ Footnote 1 ] At that time, this case was still pending before the court for sentencing.

matches: v. v. v. v. v. v. v.